BRUNO, WILLIAM
 Distribuzione geografica
Continente #
EU - Europa 4664
Totale 4664
Nazione #
IT - Italia 4664
Totale 4664
Città #
Genova 4074
Rapallo 448
Genoa 142
Totale 4664
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 142
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 138
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 129
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 121
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 117
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene 116
Identification, genetic testing, and management of hereditary melanoma 116
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 114
null 113
null 111
Signs and genetics of rare cancer syndromes with gastroenterological features 110
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 109
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations 109
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 109
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 109
Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? 106
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 105
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL 105
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 104
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 102
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 101
null 101
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 101
null 99
Selection criteria for genetic assessment of patients with familial melanoma 92
null 91
null 89
Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation 87
Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family. 86
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 85
Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT 85
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 81
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 81
Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. 76
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 76
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 75
Novel MC1R variants and phenotypic expression of red hair in Ligurian melanoma patients and controls. 70
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 69
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 67
null 67
null 65
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 65
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 64
Multiple primary melanoma (MPM) as a valid criterion for genetic assessment : an Italian IMI multi-center study 60
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 58
A case of four synchronous cutaneous melanomas: Melanocortin 1 receptor polymorphisms and excessive sun exposure 57
Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination 50
Current State of Target Treatment in BRAF Mutated Melanoma 43
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 41
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 38
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 36
Predictors of sun protection behaviors and severe sunburn in an international online study 25
Melanoma risk factors, perceived threat and intentional tanning: An international online survey 25
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 25
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 25
Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families 20
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 20
Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing 18
Definitions of genetic testing in Italian legal documents 17
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 15
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 14
Seven Synchronous Primary Melanomas on the Back 14
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 14
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 13
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 12
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 8
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 7
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 7
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 4
Molecular Assessment in Patients with Melanoma: When and Why? 3
Novel MC1R variants in Ligurian melanoma patients and controls 3
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 3
Totale 4833
Categoria #
all - tutte 7803
article - articoli 7463
book - libri 0
conference - conferenze 328
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12
Totale 15606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018363 0000 0161 4996 65451
2018/2019420 84153 922 53 360146115
2019/20201485 723969106 152165 222113 13821815536
2020/2021540 39385060 3023 2745 56745543
2021/2022760 24436278 3563 48165 54723284
2022/2023589 1158812112 22834 00 0000
Totale 4833